Literature DB >> 1420246

Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival.

R J Fischel1, A J Matas, J L Platt, E Perry, H Noreen, S J Shumway, R M Bolman.   

Abstract

Transplantation of immediately vascularized grafts across species barriers in which preformed cytotoxic antibodies exist, otherwise known as discordant combinations, has uniformly resulted in hyperacute rejection. We studied how well plasma exchange and perfusion through organs removes preformed immunoglobulin M cytotoxic antibodies and prolongs survival of a porcine heart heterotopically transplanted into a rhesus monkey. With the use of plasma exchange or absorption of antibodies by porcine kidney perfusion with or without immunosuppression, graft survival was prolonged, although antibody-mediated rejection ultimately occurred. In one case in which plasma exchange, kidney perfusion, and immunosuppression were combined, a functioning pig heart survived in a rhesus monkey for 8 days without evidence of rejection. The animal was killed on day 8 according to protocol because of a wound dehiscence. With this animal we were able to demonstrate that circulating antibodies against graft endothelium had bound to the graft endothelium without inducing rejection, a process referred to as accommodation. In this case, despite the presence of antiendothelial antibodies, complement did not appear to be activated, and fibrin thrombi did not form. Although we have achieved this rejection-free survival only in one animal, this case suggests that it may be possible to maintain xenotransplants in discordant species without rejection if preformed antibodies are appropriately lowered or altered during the initial period of graft implantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420246

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

Review 1.  Antiendothelial cell antibodies in vasculitis and connective tissue disease.

Authors:  C Belizna; A Duijvestijn; M Hamidou; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

2.  Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Authors:  Kyle A Soltys; Alejandro Soto-Gutiérrez; Masaki Nagaya; Kevin M Baskin; Melvin Deutsch; Ryotaro Ito; Benjamin L Shneider; Robert Squires; Jerry Vockley; Chandan Guha; Jayanta Roy-Chowdhury; Stephen C Strom; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2010-06-30       Impact factor: 25.083

3.  Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

Authors:  J C Magee; B H Collins; R C Harland; B J Lindman; R R Bollinger; M M Frank; J L Platt
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

4.  Porcine E-selectin: cloning and functional characterization.

Authors:  Y T Tsang; P E Stephens; S T Licence; D O Haskard; R M Binns; M K Robinson
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

5.  Heart xenograft survival with chimeric pig donors and modest immune suppression.

Authors:  William E Beschorner; Debra L Sudan; Stanley J Radio; Tianyu Yang; Kenneth L Franco; Arthur C Hill; C Carson Shearon; Scott C Thompson; Robert S Dixon; Noel D Johnson; Charles A Kuszynski; Ronald J Rubocki; Kelly F Lechtenberg; Aurelio Matamoros; Timothy C Goertzen; Ira J Fox; Alan N Langnas
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

6.  Biochemical and functional characterization of xenoreactive natural antibodies in hu-PBL-SCID mice.

Authors:  B Naziruddin; R Shiroki; S Shishido; T Howard; T Mohanakumar
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.